Issue

Vol. 64 No. 6: Advances in mechanism and treatment strategy of cancer

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with colorectal cancer: a meta-analysis

https://doi.org/10.14715/cmb/2018.64.6.16
Guoqiang Yan
Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, China
Tao Liu
Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, China
Libin Yin
Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, China
Zhenhua Kang
Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, China
Lei Wang
Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, China

Corresponding Author(s) : Lei Wang

leiwang1967@163.com

Cellular and Molecular Biology, Vol. 64 No. 6: Advances in mechanism and treatment strategy of cancer

Abstract

Studies suggest that inflammation is involved in the colorectal cancer (CRC) pathology and symptoms. This study sought to quantitatively summarize the clinical cytokine data. Multiple reports have described the proportion of Th17 cells in peripheral blood and serum levels of Th17-related cytokines in patients with colorectal cancer (CRC). To clarify the status of Th17 cells and Th17-related cytokines in CRC patients, we did a meta-analysis of the results published previously to quantitatively assess the levels of peripheral Th17 cells and serum Th17-related cytokines in patients with CRC. We searched PubMed, Embase, web of Science, Cochrane Library and China National Knowledge Infrastructure (CNKI) systematically for studies reporting the proportion of Th17 cells and the serum levels of Th17-related cytokines (IL-17, IL-17A, IL-6, IL-22, IL-23) in CRC patients. Studies measuring the proportion of Th17 cells and the serum levels of Th17-related cytokines (IL-17, IL-17A, IL-6, IL-22, IL-23) in CRC and healthy control subjects were included. Mean (standard deviation) proportion of Th17 cells and cytokine concentrations for CRC and control subjects were extracted. We assessed pooled data by using a random-effects model. We identified 1276 studies, of which 24 studies were included in the final meta-analytical processes. The quality was reliable according to the Newcastle–Ottawa Quality Assessment Scale (Case Control Studies). Compared with control subjects, CRC patients had a higher proportion of Th17 cells [2.37%, (0.53, 2.21)]; an elevated levels of serum IL-17A 1.11 pg./ml, 95%CI (0.16-2.07); an elevated levels of serum IL-6 3.42 pg/ml, 95%CI (3.14-3.70); an elevated levels of serum IL-22 1.32 pg/ml, 95%CI (0.94-1.70); an elevated levels of serum IL-23 0.16pg/ml, 95%CI(1.94-5.39). After sensitivity analysis, an elevated level of serum IL-17 was showed. The data showed that the proportion of Th17 cells in PB and levels of serum IL-17, IL-17A, IL-6, IL-22, IL-23 increased among CRC patients compared to control subjects. This result demonstrated that Th17 cells and Th17-related cytokines may be involved in the pathogenic mechanisms of CRC.

Keywords

TH 17 cells cytokines Colorectal cancer IL 17.
Yan, G., Liu, T., Yin, L., Kang, Z., & Wang, L. (2018). Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with colorectal cancer: a meta-analysis. Cellular and Molecular Biology, 64(6), 94–102. https://doi.org/10.14715/cmb/2018.64.6.16
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Stewart B, Wild CP. World cancer report 2014. Health 2017.
  2. McAllister F, Housseau F, Sears CL. Microbiota and immune responses in colon cancer: more to learn. Cancer journal (Sudbury, Mass) 2014; 20(3): 232.
  3. Kimura A, Naka T, Kishimoto T. IL-6-dependent and-independent pathways in the development of interleukin 17-producing T helper cells. Proceedings of the National Academy of Sciences 2007; 104(29): 12099-12104.
  4. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004; 21(4): 467-476.
  5. Liu SJ, Tsai JP, Shen CR et al. Induction of a distinct CD8 Tnc17 subset by transforming growth factor"β and interleukin"6. Journal of leukocyte biology 2007; 82(2): 354-360.
  6. Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. The Journal of Immunology 2010; 184(3): 1630-1641.
  7. Guo Q, Shen S, Li X, Tang K, Zhou W. Inflammatory factors promote the development of colorectal cancer. Zhong nan da xue xue bao Yi xue ban= Journal of Central South University Medical sciences 2011; 36(7): 646-649.
  8. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Revista Española De Nutrición Humana Y Dietética 2009; 18(3): e123.
  9. Mcpheeters ML. Newcastle-Ottawa Quality Assessment Scale. 2012.
  10. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemporary clinical trials 2007; 28(2): 105-114.
  11. Higgins J, Thompson SG. Quantifying heterogeneity in a meta"analysis. Statistics in medicine 2002; 21(11): 1539-1558.
  12. Zhang J. [Th17 cells and related cytokines expression in elderly colon cancer patients]. Chongqing Medical Journal 2016; 36(9).
  13. ZHANG Li-li ZY-z, ZHANG Cai-feng,XIA Yong-hua, CHANG Ting-min, HAN Yu. [Expression of Th17 and CD4+ CD25+ regulatory T cells in the peripheral blood of patients with colon cancer]. China Journal of Modern Medicine 2014; 24(11): 59-62.
  14. Guofang L. Expression of CD4+T cell subsets in colorectal carcinoma and their clinical significance, YANGZHOU UNIVERSITY; 2014.
  15. Lei Y. [Distribution and clinical significance of Th17 cells in colorectal cancer patients] SU ZHOU UNIVERSITY; 2016.
  16. Xinyi L. [Alteration of the Percentage of T Helper 17 Lymphocytes and Interleukin-6 and -17 Expression in Elderly Colorectal Cancer Patients], DaLian Medical University; 2014.
  17. Huang jiahao Cy, Gao feng. [Detection of Th1 and Th2 cells in peripheral blood of the colorectal cancer patients]. Journal of Colorectal & Anal Surgery 2012; 18(2): 71-79.
  18. al. ZXWXPQe. [The expression and clinical significance of serum IL-17 in colorectal cancer]. MMJC 2014; (4): 36-39.
  19. Mengjie WANG SS, Keqing QIAN, Haiyan MIN, Ling CEN, Chunjian QI. [Preliminary studies on the serum IL-17 and TGF-β levels and their correlations with tumor incidence and progression in colorectal cancer patients]. Chin J Clin Oncol 2013; (13): 767-769.
  20. Hui M, Fei P, Guo H et al. Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. Tumor Biology 2016; 37(9): 12223-12230.
  21. Radosavljevic GB, Jovanovic. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma 2010; 57(2): 135.
  22. LI Shubin SD. The distribution of peripheral Th17 and Th22 cells and the roles of IL-17A and IL-22 in colon cancer patients. Chinese Journal of Gastroenterology and Hepatology 2017; 26(8): 882-885.
  23. WANG Jian-Sheng TY-Q, ZHANG Li-Zhi,L Yuan-Peng,SONG Jin-Xiao. Changes of circulating Tc17 cells in progression of colorectal cancer. Chinese Journal of Immunology 2014; (6): 817-820.
  24. WANG Jiansheng ZL, TIE Yanqing, LYU Yuanpeng, SONG Jinxiao. [The Changes of Circulating Th17 and Tc17 Cells in Patients with Colorectal Polyp Adenoma and Cancer]. Tianjin Med J 2014; 42(4): 312-314.
  25. HUANG Wei-gang CR-c, XIANG Jia-liang,ZHANG Guo-an. . Expressions of serum IL-17 and IL-6 of patients with colorectal carcinoma and their clinical significance. TUMOR 2012; 32(6): 458-461.
  26. Jiansheng WANG YL, Juntao MENG, Jinxiao SONG, Lizhi ZHANG, Yanqing TIE. Expression and clinical significance of IL-23 and IL-17 in patients with colorectal cancer. Chinese Journal of Clinical Oncology 2014; (9): 580-584.
  27. Adamo V, Franchina T, Minciullo PL et al. Role of interleukin"23 circulating levels increase in resected colorectal cancer before and after chemotherapy: Preliminary data and future perspectives. Journal of Cellular Physiology 2011; 226(11): 3032-3034.
  28. Alizadeh D, Katsanis E, Larmonier N. The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer. Clinical and Developmental Immunology 2013; 2013.
  29. Ghosh S, Ashcraft K. An IL-6 link between obesity and cancer. Frontiers in bioscience (Elite edition) 2013; 5: 461-478.
  30. Li L, Boussiotis VA. The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer. Clinical immunology 2013; 148(2): 246-253.
  31. Fu B, Tian Z, Wei H. TH17 cells in human recurrent pregnancy loss and pre-eclampsia. Cellular & molecular immunology 2014; 11(6): 564.
  32. Tosolini M, Kirilovsky A, Mlecnik B et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer research 2011; 71(4): 1263-1271.
  33. Le Gouvello S, Bastuji-Garin S, Aloulou N et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008; 57(6): 772-779.
  34. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells. Nature immunology 2007; 8(9): 942.
  35. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature immunology 2009; 10(8): 857.
  36. Buonocore S, Ahern PP, Uhlig HH et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464(7293): 1371.
  37. Das J, Ren G, Zhang L et al. Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation. Journal of Experimental Medicine 2009; 206(11): 2407-2416.
  38. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 2005; 201(2): 233-240.
  39. Manel N, Unutmaz D, Littman DR. The differentiation of human T H-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nature immunology 2008; 9(6): 641.
  40. Santarlasci V, Maggi L, Capone M et al. TGF"β indirectly favors the development of human Th17 cells by inhibiting Th1 cells. European journal of immunology 2009; 39(1): 207-215.
  41. Mangan PR, Harrington LE, O'quinn DB et al. Transforming growth factor-β induces development of the T H 17 lineage. Nature 2006; 441(7090): 231.
  42. Teraishi F, Ozaki K, Shibuya Y et al. Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient. Gan to kagaku ryoho Cancer & chemotherapy 2012; 39(3): 473-475.
  43. Kouroussis C, Souglakos J, Kakolyris S et al. Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study. Oncology 2001; 61(1): 36-41.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 823 Download : 422

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.